- XLRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Acceleron Pharma (XLRN) 8-K8 Nov 19REBLOZYL is the first and only FDA-approved erythroid maturation agent, representing a new class of therapy for these patientsFinancial data
Company Profile